azathioprine has been researched along with Cystadenocarcinoma, Papillary in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Cystadenocarcinoma, Papillary: An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Teneriello, M | 1 |
Farley, J | 1 |
Parker, M | 1 |
O'Connor, D | 1 |
Shaver, T | 1 |
Park, R | 1 |
Barnhill, D | 1 |
1 other study available for azathioprine and Cystadenocarcinoma, Papillary
Article | Year |
---|---|
Management of advanced ovarian epithelial cancer in the renal transplant patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Carboplatin; Chemotherapy, Adju | 1993 |